Cargando…
HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas
SIMPLE SUMMARY: Human epidermal growth factor receptor 2 (HER2) is a transmembrane tyrosine kinase receptor whose homonymous gene is an important oncogenic driver in 10–20% of invasive breast cancer. The role of HER2 in canine mammary carcinoma is controversial; therefore, this study aimed to invest...
Autores principales: | Muscatello, L. V., Gobbo, F., Di Oto, E., Sarli, G., De Maria, R., De Leo, A., Tallini, G., Brunetti, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694975/ https://www.ncbi.nlm.nih.gov/pubmed/36356060 http://dx.doi.org/10.3390/vetsci9110583 |
Ejemplares similares
-
Immunohistochemical Screening of HER2 in Canine Carcinomas: A Preliminary Study
por: Brunetti, Barbara, et al.
Publicado: (2021) -
High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome
por: Levi, Michela, et al.
Publicado: (2021) -
Unusual Myoid Differentiation in a Canine Benign Mixed Mammary Tumour
por: Brunetti, Barbara, et al.
Publicado: (2021) -
Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?
por: Beha, Germana, et al.
Publicado: (2012) -
Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines
por: Levi, Michela, et al.
Publicado: (2021)